Assiduous: Thanks for your perspective and allbof what you surmise MAY be true. But the real problem is GNBT is not sttracting any legitimate private or institutional investors on the buy side because all confidence has been lost as no tangible products are revenue generating after years of promotion, testing, proposals, and hype.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links